These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

218 related articles for article (PubMed ID: 20582737)

  • 1. Pathogenesis of diffuse large B cell lymphoma.
    Chan WJ
    Int J Hematol; 2010 Sep; 92(2):219-30. PubMed ID: 20582737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells.
    Davis RE; Brown KD; Siebenlist U; Staudt LM
    J Exp Med; 2001 Dec; 194(12):1861-74. PubMed ID: 11748286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways.
    Lenz G; Wright GW; Emre NC; Kohlhammer H; Dave SS; Davis RE; Carty S; Lam LT; Shaffer AL; Xiao W; Powell J; Rosenwald A; Ott G; Muller-Hermelink HK; Gascoyne RD; Connors JM; Campo E; Jaffe ES; Delabie J; Smeland EB; Rimsza LM; Fisher RI; Weisenburger DD; Chan WC; Staudt LM
    Proc Natl Acad Sci U S A; 2008 Sep; 105(36):13520-5. PubMed ID: 18765795
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse large B-cell lymphoma.
    Li S; Young KH; Medeiros LJ
    Pathology; 2018 Jan; 50(1):74-87. PubMed ID: 29167021
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular profiling of diffuse large B-cell lymphoma identifies robust subtypes including one characterized by host inflammatory response.
    Monti S; Savage KJ; Kutok JL; Feuerhake F; Kurtin P; Mihm M; Wu B; Pasqualucci L; Neuberg D; Aguiar RC; Dal Cin P; Ladd C; Pinkus GS; Salles G; Harris NL; Dalla-Favera R; Habermann TM; Aster JC; Golub TR; Shipp MA
    Blood; 2005 Mar; 105(5):1851-61. PubMed ID: 15550490
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The significance of FOXP1 in diffuse large B-cell lymphoma.
    Gascoyne DM; Banham AH
    Leuk Lymphoma; 2017 May; 58(5):1037-1051. PubMed ID: 27678023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular classification, pathway addiction, and therapeutic targeting in diffuse large B cell lymphoma.
    Puvvada S; Kendrick S; Rimsza L
    Cancer Genet; 2013; 206(7-8):257-65. PubMed ID: 24080457
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Copy number abnormalities, MYC activity, and the genetic fingerprint of normal B cells mechanistically define the microRNA profile of diffuse large B-cell lymphoma.
    Li C; Kim SW; Rai D; Bolla AR; Adhvaryu S; Kinney MC; Robetorye RS; Aguiar RC
    Blood; 2009 Jun; 113(26):6681-90. PubMed ID: 19278952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and validation of immune-associated long non-coding RNA biomarkers associated with clinically molecular subtype and prognosis in diffuse large B cell lymphoma.
    Zhou M; Zhao H; Xu W; Bao S; Cheng L; Sun J
    Mol Cancer; 2017 Jan; 16(1):16. PubMed ID: 28103885
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Appropriate management of molecular subtypes of diffuse large B-cell lymphoma.
    Dunleavy K; Wilson WH
    Oncology (Williston Park); 2014 Apr; 28(4):326-34. PubMed ID: 24839807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular complexity of diffuse large B-cell lymphoma: a molecular perspective and therapeutic implications.
    Almasmoum HA
    J Appl Genet; 2024 Feb; 65(1):57-72. PubMed ID: 38001281
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Probabilistic Classification Tool for Genetic Subtypes of Diffuse Large B Cell Lymphoma with Therapeutic Implications.
    Wright GW; Huang DW; Phelan JD; Coulibaly ZA; Roulland S; Young RM; Wang JQ; Schmitz R; Morin RD; Tang J; Jiang A; Bagaev A; Plotnikova O; Kotlov N; Johnson CA; Wilson WH; Scott DW; Staudt LM
    Cancer Cell; 2020 Apr; 37(4):551-568.e14. PubMed ID: 32289277
    [TBL] [Abstract][Full Text] [Related]  

  • 13. miR-181a negatively regulates NF-κB signaling and affects activated B-cell-like diffuse large B-cell lymphoma pathogenesis.
    Kozloski GA; Jiang X; Bhatt S; Ruiz J; Vega F; Shaknovich R; Melnick A; Lossos IS
    Blood; 2016 Jun; 127(23):2856-66. PubMed ID: 26941399
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Analysis of genomic copy number alterations of malignant lymphomas and its application for diagnosis].
    Tagawa H
    Gan To Kagaku Ryoho; 2007 Jul; 34(7):975-82. PubMed ID: 17637530
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of key microRNAs associated with diffuse large B-cell lymphoma by analyzing serum microRNA expressions.
    Meng Y; Quan L; Liu A
    Gene; 2018 Feb; 642():205-211. PubMed ID: 29128636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets.
    Karube K; Enjuanes A; Dlouhy I; Jares P; Martin-Garcia D; Nadeu F; Ordóñez GR; Rovira J; Clot G; Royo C; Navarro A; Gonzalez-Farre B; Vaghefi A; Castellano G; Rubio-Perez C; Tamborero D; Briones J; Salar A; Sancho JM; Mercadal S; Gonzalez-Barca E; Escoda L; Miyoshi H; Ohshima K; Miyawaki K; Kato K; Akashi K; Mozos A; Colomo L; Alcoceba M; Valera A; Carrió A; Costa D; Lopez-Bigas N; Schmitz R; Staudt LM; Salaverria I; López-Guillermo A; Campo E
    Leukemia; 2018 Mar; 32(3):675-684. PubMed ID: 28804123
    [TBL] [Abstract][Full Text] [Related]  

  • 17. New strategies in diffuse large B-cell lymphoma: translating findings from gene expression analyses into clinical practice.
    Friedberg JW
    Clin Cancer Res; 2011 Oct; 17(19):6112-7. PubMed ID: 21844008
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Gene expression profiling of diffuse large B-cell lymphoma.
    Rosenwald A; Staudt LM
    Leuk Lymphoma; 2003; 44 Suppl 3():S41-7. PubMed ID: 15202524
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A 9 series microRNA signature differentiates between germinal centre and activated B-cell-like diffuse large B-cell lymphoma cell lines.
    Culpin RE; Proctor SJ; Angus B; Crosier S; Anderson JJ; Mainou-Fowler T
    Int J Oncol; 2010 Aug; 37(2):367-76. PubMed ID: 20596664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting the B-cell receptor pathway in diffuse large B-cell lymphoma.
    Dunleavy K; Erdmann T; Lenz G
    Cancer Treat Rev; 2018 Apr; 65():41-46. PubMed ID: 29549872
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.